Dawaa Reference

chronic

Benign Neoplasm of the Nervous System

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Anatomy, Smooth Muscle - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK532857/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class ND25.00 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

Includes non-malignant tumours such as meningioma or vestibular schwannoma that can still compress brain or nerve tissue; the GP recognises the presentation and refers for neurosurgical assessment, sometimes starting a corticosteroid or anticonvulsant for oedema or seizures while awaiting specialist review. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Includes non-malignant tumours such as meningioma or vestibular schwannoma that can still compress brain or nerve tissue; the GP recognises the presentation and refers for neurosurgical assessment, sometimes starting a corticosteroid or anticonvulsant for oedema or seizures while awaiting specialist review.

Cautions
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - A progressive focal neurological deficit, a new-onset seizure, or papilloedema or other signs of raised intracranial pressure: assess urgently and refer.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.